Phase 2 Stomach Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have signed a written consent form before any study procedures begin.
• People whose cancer tissue samples test positive for at least one of a specific set of proteins found on tumour cells (such as GD2, mesothelin, CEA, P16, MMP, Melan A, MAGE A1, MAGE A3, or MAGE A4).
• People with a general health status rated as 0, 1, or 2 on a standard medical scale (meaning able to carry out daily activities, with or without some limitations).
• People with a life expectancy of at least 3 months.
• People who are able to follow the requirements of the study as assessed by the trial team.
• People with a confirmed diagnosis of high-risk gynaecological cancer at an advanced stage (Stage III or IV, based on the FIGO classification system).
• People who are not pregnant, and who are using appropriate contraception if there is a possibility of becoming pregnant.
• People whose blood test results show adequate bone marrow function, including sufficient levels of white blood cells and platelets.
• People whose blood test results show that their kidneys and liver are functioning within acceptable ranges as defined by the trial.

Who may not be able to join:

• People whose cancer tissue samples test negative for all of the specific tumour-associated proteins being studied.
• People who have taken part in any other cell therapy trial within the past year.
• People who have received another experimental drug within the 28 days before the study start date.
• People who have had a minor surgical procedure (such as biopsy, needle aspiration, or placement of a central line) within 2 days before the study start date.
• People who are pregnant or currently breastfeeding.
• People who are unable to meet the requirements of the trial.
• People whose blood test results show that bone marrow function is below the levels required by the trial (low white blood cell count, low platelets, or low haemoglobin).
• People whose liver or kidney function test results fall outside the acceptable ranges defined by the trial.
• People who have a serious active infection that requires intravenous (IV) antibiotics at the time of screening.
• People who test positive for HIV, syphilis (Treponema pallidum), or tuberculosis (TB).

Important: Always verify eligibility with the trial site directly before applying.